🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested
The proposed study is aimed at assessing the safety and immunogenicity of r...
Status
Completed
Location
Site 55 - Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)
Start Date
2011-04
Trial ID
NCT01339923
This is a study to assess the safety, tolerability, and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2011-04-19
Trial ID
NCT01337167
Treatments Being Tested
Primary Objective: To demonstrate the non-inferiority of the SHAN6™ vaccin...
Status
Completed
Location
Investigational Site Number 7640003
Start Date
2020-06-28
Trial ID
NCT04429295
Treatments Being Tested
The purpose of this study is to determine whether an early schedule of a co...
Status
Completed
Location
Menzies School of Health Research
Start Date
2011-08
Trial ID
NCT01174849
Treatments Being Tested
The primary objectives of this study are to evaluate the immunogenicity (an...
Status
Completed
Location
Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine (MRCG at LSHTM)
Start Date
2019-07-18
Trial ID
NCT03896477
Treatments Being Tested
The goal of this study is to evaluate the safety, tolerability, and immunog...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0015)
Start Date
2018-10-18
Trial ID
NCT03620162
Treatments Being Tested
Primary Series Primary objectives * To demonstrate that the concomitant ad...
Status
Completed
Location
Sanofi Pasteur MSD Investigational Site 003
Start Date
2013-04
Trial ID
NCT01839175
Treatments Being Tested
The primary objectives of this study are to evaluate the immunogenicity and...
Status
Completed
Location
Multiple Locations
Start Date
2012-03-30
Trial ID
NCT01553279
Treatments Being Tested
The purpose of this study was to evaluate the optimal vaccination schedule ...
Status
Completed
Location
Multiple Locations
Start Date
2009-12-16
Trial ID
NCT01049035
Treatments Being Tested